GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,390.50p
   
  • Change Today:
      19.00p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,081.06m
  • Volume: 8,054,476
  • Market Cap: £56,747m
  • RiskGrade: 129

Latest ShareCast News

London close: FTSE finishes week just shy of 9,000

By Josh White

Date: Friday 18 Jul 2025

(Sharecast News) - London stocks ended higher on Friday, supported by a positive shift in investor sentiment following US consumer confidence data.

GSK ShareCast News

FDA rejects overall benefit/risk profile of GSK'... 18-Jul-2025 ShareCast
US FDA approves new format of GSK's Shingrix 17-Jul-2025 ShareCast
US FDA to review GSK bid to extend use of respir... 14-Jul-2025 ShareCast
EMA accepts marketing authorisation application ... 23-Jun-2025 ShareCast
GSK hoping to expand Arexvy usage in Japan 20-Jun-2025 ShareCast

GSK Regulatory News

Blenrep approved in the EU for multiple myeloma 24-Jul-2025 17:00 RNS
Transaction in Own Shares 24-Jul-2025 07:00 RNS
US FDA review extended for Blenrep 23-Jul-2025 17:00 RNS
Transaction in Own Shares 23-Jul-2025 07:00 RNS
Transaction in Own Shares 22-Jul-2025 07:00 RNS

GSK Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,390.50p
Change Today 19.00p
% Change 1.39 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 8,054,476
Shares Issued 4,081.06m
Market Cap £56,747m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.36% below the market average26.36% below the market average26.36% below the market average26.36% below the market average26.36% below the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Price Trend
14.1% below the market average14.1% below the market average14.1% below the market average14.1% below the market average14.1% below the market average
42.22% above the sector average42.22% above the sector average42.22% above the sector average42.22% above the sector average42.22% above the sector average
Income
79.50% above the market average79.50% above the market average79.50% above the market average79.50% above the market average79.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
30.14% below the market average30.14% below the market average30.14% below the market average30.14% below the market average30.14% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 15
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 24-Jul-2025

Time Volume / Share Price
16:25 0 @ 1,395.50p
16:00 0 @ 1,395.00p
15:10 0 @ 1,402.50p
15:18 112 @ 1,395.00p
15:06 1 @ 1,401.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page